Rémy Glantenay

Glycode SAS is a biotechnology company specializing in protein glycosylation. It develops strains of humanised microorganisms for glycosylation in order to produce active principles for the pharmaceutical industry. The company was founded by Christophe Javaud and Vincent Carré in 2004 and is headquartered in Uzerche, France.

Limousin Participations SA is a regional private equity investment firm established through the 1997 merger of SRP Limousin-Capital Croissance (founded in 1989) and ENL Développement, created in 1988 by young entrepreneurs. Since 2001 the firm has a strategic alliance with Sofimac Partners, the manager among other investment vehicles of the seed fund Le Lanceur, focused on the neighboring Massif Central region. Limousin Participations is based in Limoges in central France. Shareholders include the Limousin Region, the government-controlled private equity firm CDC Entreprises, regional savings banks, insurance companies including mutually-owned entities, private individuals and entrepreneurs.